Psoriasis

Poster 43

Long-Term Efficacy of Continuous Risankizumab in Psoriasis by Body Region: An Updated Integrated Analysis From the LIMMitless Open-Label...

19 views

PSORIASIS

Poster 44

Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments Authors: Jeffrey...

17 views

PSORIASIS

Poster 45

Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Efficacy Results in the Overall Population and Body Surface Area...

10 views

PSORIASIS

Poster 46

Long-Term Safety of Apremilast from a Pooled Analysis of 8 Randomized, Placebo-Controlled Studies of Patients with Psoriasis Authors: L....

11 views

PSORIASIS

Poster 47

Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label...

12 views

PSORIASIS

Poster 48

Pooled Efficacy and Safety Results from the DERMIS-1 and DERMIS-2 Phase 3 Trials of Once-Daily Roflumilast Cream 0.3% for Treatment of...

10 views

PSORIASIS

Poster 49

Effisayil ON, an Open-Label, Long-Term Extension Study of Spesolimab Treatment in Patients with Generalized Pustular Psoriasis: Interim...

10 views

PSORIASIS

Poster 50

Spesolimab for the Prevention of Generalized Pustular Psoriasis (GPP) Flares: Results from the Randomized, Placebo-Controlled Trial...

12 views

PSORIASIS

Poster 51

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Evaluation of...

15 views

PSORIASIS

Poster 52

Deucravacitinib Long-Term Efficacy with Continuous Treatment in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program...

29 views

PSORIASIS

Poster 53

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: 2-Year Efficacy by...

15 views

PSORIASIS

Poster 54

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Evaluation of Lipid...

14 views

PSORIASIS

Poster 55

Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild-to-Severe...

12 views

PSORIASIS

Poster 56

Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild-to-Severe Plaque Psoriasis...

10 views

PSORIASIS

Poster 57

Real-World Effectiveness and Safety in a Phase 4 Study of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis Authors:...

14 views

PSORIASIS

Poster 58

Patients’ Quality of Life in a Phase 4 Real-World Study of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis Authors: Jayme Heim, J...

11 views

PSORIASIS

Poster 59

Bimekizumab Maintenance of Response and Safety in Patients with Moderate-to-Severe Plaque Psoriasis: Results from the Open-Label...

11 views

DERM2023 POSTERS

We invite you to view the DERM2023 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.

Search by
Poster
Number

Search by Poster Number

Search by
Poster
Number